IL6 and Sepsis: Research has shown that LPS is a classical activator of AM, which binds to Toll-like receptor 4 to activate the NF-κB pathway, releasing pro-inflammatory mediators IL-6, TNF-α, etc., resulting in clinical manifestations of lung tissue injury and sepsis (56).